PER
Click for more information
0.00% 8.0¢ percheron therapeutics limited

Ann: US FDA Type C Meeting for ATL1102 in DMD, page-20

  1. Woldanorf
    994 Posts.
    lightbulb Created with Sketch. 165
    clock Created with Sketch.
    23/04/21
    10:30
    Post #: 52672852
    On a side note, I remember somewhere a conversation with someone with mention of 100 patients. This may be done with a placebo arm to the study that was yet to be decided. This would determine if interim results would be released or not IIRC
    ANP Price at posting: 21.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

WAF Drilling at Kiaka Gold Project yields 7.6 g/t intercept for West African
right-arrow Created with Sketch.
JBH JB Hi-Fi reports $9.59 billion in sales for FY 2024, snaffles home retailer E & S Trading Co
right-arrow Created with Sketch.
AVR Anteris the latest to flee a struggling ASX for Wall Street's NASDAQ
right-arrow Created with Sketch.
NEWS Finding financial stability when inflation's out of control
right-arrow Created with Sketch.
CAR Driving up revenue - & the share price today
right-arrow Created with Sketch.
STX Award of 85 MW capacity pushes Strike's Erregulla power station project closer to FID
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $72.12M
Open High Low Value Volume
8.0¢ 8.1¢ 7.7¢ $93.21K 1.183M

Buyers (Bids)

No. Vol. Price($)
1 145811 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 33389 1
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.